欧洲药用级硅胶市场，按类型（液体和固体）、凝胶面包类型（白色硅胶面包、橙色硅胶面包和蓝色硅胶面包）、形式（着色剂、润滑剂和助流剂、粘合剂、崩解剂、调味剂、胶囊、溶剂、涂料、防腐剂、填充剂和稀释剂、悬浮液、粘度剂等）、包装类型（罐、袋、小袋、小包、容器、瓶等）、色谱法（分析色谱法、制备色谱法、工艺色谱法和重力色谱法）行业趋势和预测到 2029 年。
市场分析和见解
预计欧洲药用级硅胶市场将在 2022 年至 2029 年的预测期内实现显着增长。Data Bridge Market Research 分析，在 2022 年至 2029 年的预测期内，该市场将以 2.8% 的复合年增长率增长，预计到 2029 年将达到 30,827.59 万美元。推动药用级硅胶市场增长的主要因素是药物需求的不断增长、制药行业的广泛部署或研发，以及使用色谱法检测分子成分的生物技术支出的增加。
硅胶作为固定相被广泛接受为柱层析以及其他分离技术中使用的顶级吸附剂之一。其主要优点之一是其极强的吸附亲和力。此外，它在商业上很容易获得，有多种不同的尺寸和类型。硅胶用作柱层析固定相的主要原因是，它能够获得特定方法所需的萃取物颗粒大小。
硅胶是一种极性吸附剂，呈弱酸性，对碱性物质有很强的吸附能力。硅胶在反相分离色谱法中应用最为广泛，其应用范围广泛，包括类固醇、氨基酸、脂质、生物碱的分离以及多种制药工艺。
欧洲药用级硅胶市场报告提供了市场份额、新发展、国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（千美元）、销量（千吨）、定价（美元） |
|
涵盖的领域 |
By Type (Liquid And Solid), Gel Breads Type (White Silica Gel Breads, Orange Silica Gel Breads, and Blue Silica Gel Breads), Form (Colorants, Lubricants & Glidants, Binders, Disintegrants, Flavoring Agents, Capsules, Solvents, Coatings, Preservatives, Fillers & Diluents, Suspension, Viscosity Agents And Others), Packaging Type (Canisters, Pouches, Sachets, Packets, Containers, Bottles, and Others), Chromatography (Analytical Chromatography, Preparative Chromatography, Process Chromatography, and Gravity Chromatography) |
|
Countries Covered |
Germany, U.K., France, Italy, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands and Rest of Europe. |
|
Market Players Covered |
BASF SE, DuPont, Solvay, Merck KGAA, W. R. Grace & Co.-Conn, Evonik Industries AG, Multisorb Technologies, Clariant AG, Fuji Silysia Chemical |
Pharmaceutical Grade Silica Gel Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Demand for Medicinal Drugs
The growing pharmaceutical industry has propelled the growth of drug production, which has increased the consumption of silica gel over the years. The demand for silica gel is expected to increase further as chromatography can be performed using silica gel. Silica gel column chromatography is widely used in the pharmaceutical industry to collect or separate different drug components.
- Extensive Deployment of R&D in the Pharma Sector
The growing need for data integrity and automation has led to the integration of sophisticated software with contemporary chromatography systems. These advances in technology for the development of improved systems, innovative and disposable columns, better-performing resins, and other accessories may help the market to grow significantly.
- Rising Spending on Biotechnology using Chromatography for Detecting Molecular Components
Bioencapsulation involves the envelopment of tissues or biologically active substances in a semipermeable membrane to protect the enclosed biological structures such as cells, enzymes, drugs, and magnetic materials among others. The continuous research and development of silica gel based techniques like chromatography from the biotech end will lead to the growth of the Europe pharmaceutical grade silica gel market.
Opportunities
- Lucrative Outlook Towards In-House R&D
Chromatography is a continuously evolving technique and an increase in the demand for chromatography instruments and reagents for research and development is a major factor driving the growth and demand for the Europe pharmaceutical grade silica gel market.
- Easy Availability of Raw Materials through Well-Established Strategic Partners
The amorphous form of silicon dioxide is used to manufacture pharmaceutical-based silica gel. The enormous availability of different raw materials on the earth’s surface as well the ability to synthetically produce these raw materials along with the companies’ producing pharmaceutical grade silica gel well-established partnerships with various suppliers and partners, which continuously supply high-grade raw materials to these players for the production of silica gel.
Restraints/Challenges
- Stringent Regulations by the Government
USP's drug standards are enforceable in the U.S. by the Food and Drug Administration (FDA) and are also used in more than 140 countries across the globe. In the Pharmacy Act 1948 of India, there are various stringent regulations regarding the composition of drugs, which requires the pharmacists/chemists to follow various procedures and screening to get approved by the government. These stringent rules and regulations might be one of the biggest restraints faced by the Europe pharmaceutical-grade silica gel market.
- The Availability of Substitutes
Free silanols on the surface of silica are responsible for detrimental interactions of those compounds and the stationary phase. These show bad peak shape and low efficiency. This has also inclined manufacturers to opt for substitutes present in the market. For these reasons, several new stationary phases such as non-silica stationary phases, which have reduced and/or shielded silanols, are being introduced into the market.
- Pharmaceutical Items Meet Stringent Quality Control and Performance Standards
Across the globe, every government allocates a substantial proportion of its total health budget to medicines and pharmaceutical items. In developing countries, considerable administrative and technical efforts are directed to ensure that the patients and consumers receive effective medicines of good quality without any compromise on the quality.
- Limited Application Scope to Non-Volatile Compounds
The temperature of the system using silica gel for volatile compounds needs to be maintained at lower levels so that the compound does not vaporize very fast and there is a total loss of the sample before it is utilized and separated by the silica gel plate. Therefore, the scope of silica gel’s application is limited to non-volatile compounds, which may challenge the growth of the Europe pharmaceutical grade silica gel market.
Recent Development
- In February 2022, DuPont launched a new online sales portal for the needs of bioprocessing industry purchasers. DuPont bioprocessing enables sophisticated separations and purification for therapeutics, with different DuPont brands such as AmberChrom and AmberLite being very well established in the biopharma industry.
Europe Pharmaceutical Grade Silica Gel Market Scope
欧洲药用级硅胶市场根据类型、凝胶面包、形式、包装类型和色谱法进行分类。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，以做出战略决策，确定核心市场应用。
类型
- 坚硬的
- 液体
根据类型，欧洲药用级硅胶市场分为固体和液体。
凝胶面包类型
- 白色硅胶面包
- 橙色硅胶面包
- 蓝色硅胶面包
根据凝胶面包类型，欧洲药用级硅胶市场分为白色硅胶面包、橙色硅胶面包和蓝色硅胶面包。
形式
根据形式，欧洲药用级硅胶市场分为着色剂、润滑剂和助流剂、粘合剂、崩解剂、调味剂、胶囊、溶剂、涂料、防腐剂、填充剂和稀释剂、悬浮液、粘度剂以及其他医院和诊所、诊断中心、学术机构等。
包装类型
- 袋装
- 小袋
- 数据包
- 罐子
- 容器
- 瓶子
- 其他的
根据包装类型，欧洲药用级硅胶市场分为罐、袋、小袋、小包、容器、瓶子和其他。
色谱法
- 分析色谱法
- 制备色谱法
- 过程色谱法
根据色谱法，欧洲药用级硅胶市场分为分析色谱法、制备色谱法、工艺色谱法和重力色谱法。
医药级硅胶市场区域分析/见解
对药用级硅胶市场进行了分析，并按国家、类型、凝胶面包类型、形式、包装类型和色谱法提供了市场规模见解和趋势。
欧洲市场分为德国、英国、法国、意大利、西班牙、俄罗斯、瑞士、土耳其、比利时、荷兰和欧洲其他地区。
德国在市场份额和市场收入方面占据欧洲药用级硅胶市场的主导地位，并将在预测期内继续保持主导地位。这是由于该国拥有主要的关键参与者和发达的医疗保健基础设施。
报告的国家部分还提供了影响单个市场因素和市场法规变化，这些因素和变化会影响市场的当前和未来趋势。新车和替换车销售、国家人口统计数据和进出口关税等数据点是预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。
竞争格局和欧洲药用级硅胶市场份额分析
欧洲药用级硅胶市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对药用级硅胶市场的关注有关。
欧洲药用级硅胶市场的一些知名参与者包括 BASF SE、杜邦、索尔维、默克、WR Grace & Co.-Conn、赢创工业股份公司、Multisorb Technologies、科莱恩股份公司、富士硅化学。
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、欧洲与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 DBMR MARKET CHALLENGE MATRIX
2.11 DBMR VENDOR SHARE ANALYSIS
2.12 IMPORT-EXPORT DATA
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER’S FIVE FORCES:
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 THREAT OF SUBSTITUTES
4.2.3 CUSTOMER BARGAINING POWER
4.2.4 SUPPLIER BARGAINING POWER
4.2.5 INTERNAL COMPETITION (RIVALRY)
4.3 CLIMATE CHANGE SCENARIO
4.4 RAW MATERIAL PRODUCTION COVERAGE
4.5 TECHNOLOGY ADVANCEMENTS
4.6 REGULATORY COVERAGE
4.7 SUPPLY CHAIN ANALYSIS
4.7.1 OVERVIEW
4.7.2 RAW MATERIAL PROCUREMENT
4.7.2.1 MANUFACTURING AND PACKING
4.7.2.2 MARKETING AND DISTRIBUTION
4.7.2.3 END USERS
4.7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.8 VENDOR SELECTION CRITERIA
5 REGIONAL SUMMARY
5.1 EUROPE
5.2 ASIA-PACIFIC
5.3 EUROPE
5.4 NORTH AMERICA
5.5 MIDDLE EAST AND AFRICA
5.6 SOUTH AMERICA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING DEMAND FOR MEDICINAL DRUGS
6.1.2 EXTENSIVE DEPLOYMENT OF R&D IN THE PHARMA SECTOR
6.1.3 RISING EXPENSES ON BIOTECHNOLOGY USING CHROMATOGRAPHY FOR DETECTING MOLECULAR COMPONENTS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS BY THE GOVERNMENT
6.2.2 AVAILABILITY OF SUBSTITUTES
6.2.3 RESTRICTIONS ON DERMAL AND ORAL EXPOSURE TO PHARMACEUTICAL GRADE SILICA GEL
6.2.4 HIGH PRICE OF SILICA GEL
6.3 OPPORTUNITIES
6.3.1 LUCRATIVE OUTLOOK TOWARDS IN-HOUSE R&D
6.3.2 EASY AVAILABILITY OF RAW MATERIALS THROUGH WELL-ESTABLISHED STRATEGIC PARTNERS
6.4 CHALLENGES
6.4.1 PHARMACEUTICAL ITEMS MEET STRINGENT QUALITY CONTROL AND PERFORMANCE STANDARDS
6.4.2 LIMITED APPLICATION SCOPE TO NON-VOLATILE COMPOUNDS
7 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE
7.1 OVERVIEW
7.2 SOLID
7.3 LIQUID
8 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE
8.1 OVERVIEW
8.2 WHITE SILICA GEL BEADS
8.3 ORANGE SILICA GEL BEADS
8.4 BLUE SILICA GEL BEADS
9 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM
9.1 OVERVIEW
9.2 FILLERS & DILUENTS
9.3 BINDERS
9.4 DISINTEGRANTS
9.5 LUBRICANTS & GLIDANTS
9.6 COLORANTS
9.7 FLAVORING AGENTS
9.8 PRESERVATIVES
9.9 SOLVENTS
9.1 CAPSULES
9.11 VISCOSITY AGENTS
9.12 SUSPENSION
9.13 COATINGS
10 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE
10.1 OVERVIEW
10.2 POUCHES
10.3 SACHETS
10.4 PACKETS
10.5 CANISTERS
10.6 CONTAINERS
10.7 BOTTLES
10.8 OTHERS
11 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY
11.1 OVERVIEW
11.2 ANALYTICAL CHROMATOGRAPHY
11.3 PREPARATIVE CHROMATOGRAPHY
11.4 PROCESS CHROMATOGRAPHY
11.5 GRAVITY CHROMATOGRAPHY
12 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 SWITZERLAND
12.1.8 TURKEY
12.1.9 BELGIUM
12.1.10 NETHERLANDS
12.1.11 REST OF EUROPE
13 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
13.1.1 COLLABORATIONS
13.1.2 EXPANSIONS
13.1.3 NEW PRODUCT DEVELOPMENTS
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 BASF SE
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT UPDATE
15.2 DUPONT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT UPDATES
15.3 SOLVAY
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT UPDATES
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT UPDATE
15.5 W. R. GRACE & CO.-CONN
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT UPDATE
15.6 EVONIK INDUSTRIES AG
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT UPDATES
15.7 CLARIANT
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT UPDATES
15.8 DESICCARE, INC
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT UPDATE
15.9 FUJI SILYSIA CHEMICAL LTD
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT UPDATE
15.1 INTERRA EUROPE
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT UPDATE
15.11 MULTISORB
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT UPDATE
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 IMPORT DATA OF SILICON DIOXIDE; HS CODE - PRODUCT: 281122 (USD THOUSAND)
TABLE 2 EXPORT DATA OF SILICON DIOXIDE; HS CODE - PRODUCT: 281122 (USD THOUSAND)
TABLE 3 REGULATORY FRAMEWORK
TABLE 4 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 5 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 6 EUROPE SOLID IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 7 EUROPE SOLID IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (KILO TONS)
TABLE 8 EUROPE LIQUID IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 9 EUROPE LIQUID IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (KILO TONS)
TABLE 10 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 11 EUROPE WHITE SILICA GEL BEADS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 12 EUROPE ORANGE SILICA GEL BEADS IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 13 EUROPE BLUE SILICA GEL BEADS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 14 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 15 EUROPE FILLERS & DILUENTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 16 EUROPE BINDERS IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 17 EUROPE DISINTEGRANTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 18 EUROPE LUBRICANTS & GLIDANTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 19 EUROPE COLORANTS IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 20 EUROPE FLAVORING AGENTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 21 EUROPE PRESERVATIVES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 22 EUROPE SOLVENTS IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 23 EUROPE CAPSULES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 24 EUROPE VISCOSITY AGENTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 25 EUROPE SUSPENSION IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 26 EUROPE COATINGS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 27 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 28 EUROPE POUCHES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 29 EUROPE SACHETS IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 30 EUROPE PACKETS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 31 EUROPE CANISTERS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 32 EUROPE CONTAINERS IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 33 EUROPE BOTTLES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 34 EUROPE OTHERS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 35 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 36 EUROPE ANALYTICAL CHROMATOGRAPHY IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 37 EUROPE PREPARATIVE CHROMATOGRAPHY IN EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 38 EUROPE PROCESS CHROMATOGRAPHY IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 39 EUROPE GRAVITY CHROMATOGRAPHY IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 40 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)
TABLE 41 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY COUNTRY, 2020-2029 (KILO TONS)
TABLE 42 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 43 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 44 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 45 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 46 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 47 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 48 GERMANY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 49 GERMANY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 50 GERMANY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 51 GERMANY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 52 GERMANY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 53 GERMANY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 54 U.K. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 55 U.K. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 56 U.K. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 57 U.K. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 58 U.K. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 59 U.K. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 60 FRANCE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 61 FRANCE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 62 FRANCE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 63 FRANCE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 64 FRANCE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 65 FRANCE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 66 ITALY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 67 ITALY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 68 ITALY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 69 ITALY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 70 ITALY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 71 ITALY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 72 SPAIN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 73 SPAIN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 74 SPAIN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 75 SPAIN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 76 SPAIN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 77 SPAIN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 78 RUSSIA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 79 RUSSIA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 80 RUSSIA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 81 RUSSIA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 82 RUSSIA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 83 RUSSIA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 84 SWITZERLAND PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 85 SWITZERLAND PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 86 SWITZERLAND PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 87 SWITZERLAND PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 88 SWITZERLAND PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 89 SWITZERLAND PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 90 TURKEY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 91 TURKEY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 92 TURKEY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 93 TURKEY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 94 TURKEY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 95 TURKEY PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 96 BELGIUM PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 97 BELGIUM PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 98 BELGIUM PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 99 BELGIUM PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 100 BELGIUM PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 101 BELGIUM PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 102 NETHERLANDS PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 103 NETHERLANDS PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 104 NETHERLANDS PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 105 NETHERLANDS PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 106 NETHERLANDS PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 107 NETHERLANDS PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 108 REST OF EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 109 REST OF EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
图片列表
FIGURE 1 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: SEGMENTATION
FIGURE 2 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: TYPE LIFE LINE CURVE
FIGURE 7 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: MULTIVARIATE MODELLING
FIGURE 8 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: DBMR MARKET POSITION GRID
FIGURE 10 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: CHALLENGE MATRIX
FIGURE 11 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: SEGMENTATION
FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 GROWING DEMAND FOR MEDICINAL DRUGS IS EXPECTED TO DRIVE EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET IN THE FORECAST PERIOD
FIGURE 15 SOLID SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET IN 2022 & 2029
FIGURE 16 SUPPLY CHAIN ANALYSIS- EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET
FIGURE 17 VENDOR SELECTION CRITERIA
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET
FIGURE 19 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY TYPE, 2021
FIGURE 20 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY GEL BEADS TYPE, 2021
FIGURE 21 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY FORM, 2021
FIGURE 22 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY PACKAGING TYPE, 2021
FIGURE 23 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY CHROMATOGRAPHY, 2021
FIGURE 24 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET : SNAPSHOT (2021)
FIGURE 25 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY COUNTRY (2021)
FIGURE 26 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY COUNTRY (2022 & 2029)
FIGURE 27 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY COUNTRY (2021 & 2029)
FIGURE 28 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: BY TYPE (2022-2029)
FIGURE 29 EUROPE PHARMACEUTICAL GRADE SILICA GEL MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
